Mike is an Assistant Professor and the Hunt Faculty Scholar in the Departments of Biomedical Engineering and Chemistry at Duke University. Work in the Lynch lab is focused on developing advanced tools for metabolic engineering with a long-term goal to develop readily accessible tools for the predictable rational design of industrial strains. These tools are being developed alongside key applications ranging from the production of biofuels and chemicals to next-generation therapeutics and materials. Mike has recently co-founded DMC Biotechnologies Inc., a start-up commercializing dynamic metabolic control technology developed at Duke. Mike received his A.B., B.S. and M.S. from Washington University in St. Louis and his Ph.D. and M.D. from the University of Colorado. Prior to moving to Duke, Mike was the co-founder and CSO of OPX Biotechnologies , Inc , a start-up founded to commercialize technology out of the Gill Laboratory at the University of Colorado.